madam-therapeutics.com Report : Visit Site

Technical data of the madam-therapeutics.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host madam-therapeutics.com. Currently, hosted in Netherlands and its service provider is DirectVPS B.V. .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.2.14 (Ubuntu) containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

home antimicrobial resistance lack of development of novel antibiotics the cost of antimicrobial resistance key facts on antimicrobial resistance technology how do synthetic anti-microbial and anti-biofilm peptides (saaps) work? saap-148 is active against a broad spectrum of gram-negative and gram-positive bacteria how saaps help to fight biofilm formation pipeline saap-148: optimized peptide for use in wound care our products saap-148 gel for chronic wounds saap148 dressing for burn wounds why burns are a very relevant area for madam therapeutics saap-148 nose application to fight mrsa business team investors news publications scientific media contact privacy policy cookies home new strategies in the treatment of infections are warranted, as antibiotic resistance (antimicrobial resistance, amr) is emerging. this resistance will increase over the coming years and decades because of the excessive use of traditional antibiotics in humans and animals. currently 700.000 annual deaths are contributed to antimicrobial resistance, but estimations tell us that by 2050 amr will be responsible for about 10 million deaths annually, surpassing cancer and diabetes in annual fatalities. globally amr is viewed more and more as a significant public health threat. madam therapeutics’ is a privately held company from the netherlands that is developing synthetic anti-microbial and anti-biofilm peptides (saaps) to combat resistant bacterial infections. our saaps are highly active against such bacteria and have a very favorable tolerance profile. our saaps combine two characteristics essential for such new strategies: powerful killing of bacteria and limited likelihood of emerging resistance. tweet follow @remkovanleeuwen latest news emergence of a new multidrug-resistant escherichia coli clone in the united states july 12, 2018 ‘most important antibiotic legislation in a generation’ discussed in us house of representatives july 2, 2018 rise of carbapenem-resistant enterobactericaeae: a threat to health in europe june 29, 2018 madam therapeutics ceo remko van leeuwen speaks at europe’s first human and animal health business summit june 20, 2018 urgent need for saaps as new study shows that antimicrobial resistance continues to increase despite a drop in the amount of antibiotics prescribed by general practioners june 7, 2018 you can meet us at the following events: 22nd international aids conference, amsterdam, the netherlands july 23 - july 27 12th berlin conference on life sciences /amr, berlin, germany march 14, 2019 - march 15, 2019 view all events follow us on twitter tweets by @remkovanleeuwen copyright © 2018 madam therapeutics . theme by colorlib powered by wordpress madam therapeutics, amstelkade 39a, 3652me woerdense verlaat, the netherlands. phone +31 71 2040 105 (choose extension 103 or 203). email info [at] madam.therapeutics.com this website uses cookies to improve your experience. we use cookies to help give you the best experience on our website. by continuing without changing your cookie settings, we assume you agree to this. you can opt-out if you wish, see read more for instruction how to do this. accept read more

URL analysis for madam-therapeutics.com

https://www.madam-therapeutics.com/index.php/address-details/
https://www.madam-therapeutics.com/index.php/our-products/p148-dressing-for-burn-wounds/why-burns-are-a-very-relevant-area-for-madam-therapeutics/
https://www.madam-therapeutics.com/index.php/business/
https://www.madam-therapeutics.com/index.php/p148-optimized-peptide-for-use-in-wound-care/
https://www.madam-therapeutics.com/index.php/how-do-antimicrobial-peptides-amps-work/
https://www.madam-therapeutics.com/index.php/how-saaps-help-to-fight-biofilm-formation/
https://www.madam-therapeutics.com/index.php/2018/06/07/urgent-need-for-saaps-as-new-study-shows-that-antimicrobial-resistance-continues-to-increase-despite-a-drop-in-the-amount-of-antibiotics-prescribed-by-general-practioners/
https://www.madam-therapeutics.com/index.php/team/
https://www.madam-therapeutics.com/index.php/2018/06/29/rise-of-carbapenem-resistant-enterobactericaeae-a-threat-to-health-in-europe/
https://www.madam-therapeutics.com/index.php/event/12th-berlin-conference-on-life-sciences-amr-14-15-march-2019-berlin-germany/
https://www.madam-therapeutics.com/index.php/our-products/p10-cream-for-atopic-dermatitis/
https://www.madam-therapeutics.com/index.php/privacy-policy/
https://www.madam-therapeutics.com/index.php/antimicrobial-resistance/lack-of-development-of-novel-antibiotics/
https://www.madam-therapeutics.com/index.php/media/
https://www.madam-therapeutics.com/index.php/pipeline/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: MADAM-THERAPEUTICS.COM
Registry Domain ID: 1560746384_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.yoursrs.com
Registrar URL: http://www.realtimeregister.com
Updated Date: 2017-06-30T07:19:00Z
Creation Date: 2009-06-29T13:30:23Z
Registry Expiry Date: 2018-06-29T13:30:23Z
Registrar: RealTime Register BV
Registrar IANA ID: 839
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: ok https://icann.org/epp#ok
Name Server: NS3.FIRSTFIND.NL
Name Server: NS4.FIRSTFIND.NL
Name Server: NS5.FIRSTFIND.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-11-14T16:17:24Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR RealTime Register BV

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =madam-therapeutics.com

  PORT 43

  TYPE domain

DOMAIN

  NAME madam-therapeutics.com

  CHANGED 2017-06-30

  CREATED 2009-06-29

STATUS
ok https://icann.org/epp#ok

NSERVER

  NS3.FIRSTFIND.NL 85.158.203.142

  NS4.FIRSTFIND.NL 93.94.226.155

  NS5.FIRSTFIND.NET 213.136.15.188

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .